Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma

Despite stringent selection criteria, hepatocellular carcinoma recurrence after liver transplantation (LT) still occurs in up to 20% of cases, mostly within the first 2–3 years. No adjuvant treatments to prevent such an occurrence have been developed so far. However, a balanced use of immunosuppress...

Descripción completa

Detalles Bibliográficos
Autores principales: Sposito, Carlo, Citterio, Davide, Virdis, Matteo, Battiston, Carlo, Droz Dit Busset, Michele, Flores, Maria, Mazzaferro, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494935/
https://www.ncbi.nlm.nih.gov/pubmed/36160651
http://dx.doi.org/10.3748/wjg.v28.i34.4929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494935/
https://www.ncbi.nlm.nih.gov/pubmed/36160651
http://dx.doi.org/10.3748/wjg.v28.i34.4929

Ejemplares similares